Brean Digs Into Osiris Therapeutics 10Q, Downgrades To Sell
November 17, 2015 at 08:16 AM EST
Osiris Therapeutics, Inc. (NASDAQ: OSIR) shares are down 19 percent in the last three months, even after hitting a high at $21.13 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.